Association of the interleukin-10 distal promoter (-2763A/C) polymorphism with late-onset psoriasis

Clinical and Experimental Dermatology

Volumn 33, Issue 2, 2008, Pages 186-189

  Wongpiyabovorn, J ^a   Hirankarn, N ^a   Ruchusatsawat, K ^b   Yooyongsatit, S ^a   Asawanonda, P ^a   Poovorawan, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS VULGARIS; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSORIASIS;

EID: 38849204868     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02628.x     Document Type: Article

References (10)

1. Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993 101 : 701 5.
2. Asadullah K, Sterry W, Stephanek K et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998 101 : 783 94.
3. Litjens NH, Nibbering PH, Barrois AJ et al. Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines. Br J Dermatol 2003 148 : 444 51.
4. Gibson AW, Edberg JC, Wu J et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001 166 : 3915 22.
5. Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al. The synergistic effect of FC gamma receptor IIa and interleukin-10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 2006 68 : 399 406.
6. Kingo K, Koks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003 4 : 455 7.
7. Craven NM, Jackson CW, Kirby B et al. Cytokine gene polymorphisms in psoriasis. Br J Dermatol 2001 144 : 849 53.
8. Edwards-Smith CJ, Jonsson JR, Purdie DM et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999 30 : 526 30.
9. Chong WP, Ip WK, Wong WH et al. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 2004 5 : 484 92.
10. Moraes MO, Santos AR, Schonkeren JJ et al. Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics 2003 54 : 896 9.